
HCPs and patients are demanding personalised, streamlined experiences. Hemal Somaiya, Chief Strategy Officer, PharmaForceIQ, discusses how optichannel engagement offers a …
Ofichem acquires US drug substance CDMO Kinentia
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine

